We present molecular and protein profiling of all acetylcholine receptors (ACh-R) in human scalp skin using PCR, in situ hybridization and double-labeling immunofluorescence. Within the epidermis, the nicotinic (n)ACh-R subunits, a3, a5, b2, and b4 were expressed in the basal cell layer (BCL) and in a single cell layer in the stratum granulosum; a9 was expressed in the basal and lower spinous layers. a7, a10, and b1 were preferentially detected in the upper spinous and granular layers. Of the muscarinic (m)ACh-R, m1 and m4 were found in the suprabasal layers, whereas m2, m3, and m5 remained restricted to the lower layers. In the outer root sheath of the hair follicle, all ACh-R except a9, b1, and m4 were found in the BCL whereas the a9, m4, and m5 ACh-R were restricted to the central cell layer. The a5, b1, b2, m1-m4 chains were strongly expressed in the inner root sheath. Undifferentiated sebocytes expressed the a3, a9, b4, m3-m5 ACh-R whereas a7, b2, b4, m2, and m4 were found in mature sebocytes. In sweat glands, the a3 Ã , a7, and m2-m5 ACh-R were most prominent in the myoepithelial cells whereas a9, b2, m1, m3, and m4 ACh-R were present in the acinar cells. Taken together, our data result in a complete molecular map of the extraneuronal cholinergic system of the skin that may be translated into distinct functional reaction patterns.
Epidermal differentiation is a highly complex process that can be influenced by various factors such as calcium ions, vitamin A or D, growth hormones or cytokines (Fuchs, 1990) . Acetylcholine (ACh-R) and its nicotinic (nACh-R) and muscarinic (mACh-R) receptors are produced extraneuronally in the tegumental cells covering the inner and outer surfaces of the body. ACh has been found to influence the terminal differentiation of keratinocytes that produce, store, secrete, and degrade this transmitter (Grando et al, 1993) . ACh is degraded by acetycholinesterase (AChE), one of most potent enzymes in the human body that is present in high concentration in the blood (Wessler et al, 1999) . Consequently, ACh can only act as a local cytotransmitter in an autocrine or paracrine fashion. In contrast, choline, the main degradation product of ACh is stable and can act ''hormone-like'' over longer distances (Papke et al, 1996; Alkondon et al, 1997; Grando, 1997) . It is well established that keratinocytes grow better in culture if choline is present and hence virtually all culture media for keratinocytes contain $ 10
À4
-10 À5 M choline chloride (Gordon et al, 1988) . Recently, it has been proposed that ACh is also involved in ''apoptotic secretion'', a process that occurs during the transition of differentiating keratinocytes from the stratum granulosum to the stratum corneum (Nguyen et al, 2001) .
Human nACh-R are composed of different subunits, i.e. a1-a10, b1-b4, g, d, and e that can be combined to pharmacologically distinct pentameric ion channels. The a1, b1, g (only fetal), d and e (adult) chains form heteropentamers present at the neuromuscular junction. The neuronal heteropentamers that contain the a3 subunit together with other subunits are also termed a3 Ã nACh-R. The a7 and a9 subunits form homopentamers and are mainly permeable for calcium whereas the a3 Ã nACh-R are also permeable for other ions like sodium or potassium. (Lukas et al, 1999; Millar, 2003) . Recently it has been suggested that a9 subunits may form heteromeric nACh-R together with a10 subunits (Sgard et al, 2001) . Depending on their subunit composition, the nACh-R show different affinities to ACh, choline, and other cholinergic compounds like nicotine. Therefore, it is crucial to exactly map the distribution of the subunits in human epidermis if their function is to be elucidated under physiological and pathological conditions. So far, in the epidermis, mRNA of the a3, a5, a7, a9, a10, b2, and b4 subunits has been found by PCR. The exact distribution of the nACh-R, however, on mRNA and protein levels has remained vague (Raftery et al, 1980; Elgoyhen et al, 1994; Grando et al, 1995; Nguyen et al, 2001; Sgard et al, 2001; Arredondo et al, 2002) .
Hitherto, five molecular subtypes of mACh-R have been identified. They are single subunit, transmembrane glycoproteins, of which m2 and m4 are coupled to G-proteins of the G i family that upon activation lead to inhibition of adenylatcyclase. The m1, m3, and m5 subunits are coupled to G-proteins of the G q class and act specifically over signaling cascades on phospholipase C or D, thus regulating intracellular calcium levels. The mACh-R have been mapped to different layers of the epidermis, their functional role, however, has remained elusive (Grando et al, 1995; Ndoye et al, 1998; van Koppen and Kaiser, 2003) .
Since the extraneuronal cholinergic system has been implied in basic functions of the skin such as terminal differentiation and barrier formation, sweat and sebum secretion and microcirculation (Longmore et al, 1985; Smith et al, 1992; Schafer et al, 2001; Arredondo et al, 2002) , we examined ACh-R gene expression in human skin on the mRNA and protein levels. Using affinity purified polyclonal antisera raised in different species, we performed colocalization studies, providing an exact map of the ACh-R composition in scalp epidermis and adnexal structures that may be translated into distinct functional reaction patterns.
Results
Presence of ACh-R mRNA in human skin: PCR We first analyzed the presence of ACh-R mRNA in the skin by PCR and in situ hybridization (ISH). Using PCR, specific signals for the a1, a2, a4, a6, and b3 nACh-R could not be amplified from human scalp split skin cDNA. a8 subunits only occur in chicken and were therefore not examined. In contrast, for all mACh-R and the a3, a5, a7, a9, a10, b1, b2, and b4 nACh-R, specific bands could be amplified (Fig 1) . The identity of all bands was of expected sizes and was confirmed by sequencing. In cDNA samples of human skin from other body sites, including back, leg and footsole, there was a considerable, reproducible variability in the results obtained. In cDNA from back skin we did not detect m1 and m3 but m2, m4, and m5 ACh-R mRNA (not shown). Amplification of pyruvate dehydrogenase (PDH) yielded only a single band of 101 bp, indicating the absence of genomic DNA. Hence, reaction products obtained for the intronless mACh-R can be considered to result from mRNA transcripts.
Distribution of nACh-R mRNA in human skin detected by non-radioactive ISH (NR-ISH) We focused our interest on the nACh-R, since the distribution of the mACh-R seemed to be less controversial. We found a prominent a3 mRNA signal in the basal cell layer (BCL) and in the stratum granulosum. In the stratum spinosum the staining intensity varied considerably, in some specimens being truly negative. Myoepithelial cells of sweat gland acini and ductal cells were brightly labeled (Fig 2a) ; a5 signals were restricted to the basal and immediately suprabasal layers. Only in some sections, single cells in the stratum granulosum also produced a strong signal (Fig 2b) . Myoepithelial cells of sweat gland acini and ductal cells were brightly labeled. a7 signals were enriched in the upper stratum spinosum and in the stratum granulosum (Fig 2c) . In the upper outer root sheath (ORS), there was a strong signal in the BCL. In sweat glands, a strong signal could be detected in myoepithelial cells of the acini and in luminal cells of the ducts. a9 labeling could be detected in the BCL of all specimens examined (Fig 2d ) . The suprabasal layers were variably stained, in some sections reaching to the stratum granulosum. b1 reactivity could be detected in the BCL of the upper ORS. In the epidermis, the strongest staining was found in the upper stratum spinosum and in the stratum granulosum (Fig 2e) . There was no reactivity in sweat glands and sebaceous glands. b2 signals were generally weak and predominantly found in the epidermal BCL; in some sections, there was an additional signal from single cells in the stratum granulosum (not shown). b4 showed an extremely variable labeling pattern; in some sections the strongest signal could be found in the BCL (Fig 2f ) , whereas in other sections, the strongest signals were found in the stratum spinosum and stratum granulosum.
Immunolocalization of Ach-R: general observations Having determined the presence of different ACh-R mRNA in the epidermis, we performed extensive immunolocalization studies with ACh-R antisera from different species and different sources (own, Biotrend, Santa Cruz, Sigma-Aldrich). For all sera tested, there was a considerable difference in staining intensity and in staining quality depending on the fixation method used. For most sera, the best results were achieved using unfixed or acetone fixed sections. Particularly Biotrend sera did not yield the expected (and published) results if the recommended fixation method, 4% paraformaldehyde containing 7% sucrose was applied.
From all the Santa Cruz nACh-R sera tested, only the rabbit a5 serum yielded a reproducible staining of the epidermal BCL. All other sera did not produce specific immunofluorescence signals in human scalp skin with any of the fixation methods used. Acetone fixed mouse brain that was used as positive control showed strong signals. Whether these were specific, could not be assessed in the context of this study. We therefore excluded all Santa Cruz sera from immunolocalization studies.
Analyzing skin specimens from different body sites, we found interindividually and intraindividually highly variable staining patterns. Therefore, we focused our studies on scalp skin of middle-aged non-smokers. A summary of all immunolocalization results is provided in Table III . Amplification of acetylcholine receptors (ACh-R) mRNA from scalp skin. Using PCR, specific signals could be produced for the m1-m5 muscarinic ACh-R (mACh-R) and a3, a5k, a7, a9, a10, b1, b2, and b4 subunits from non-smoker's scalp skin. All bands correspond to expected sizes. Amplification of a10 transcript using the same a10 primers and PCR conditions as described by Sgard et al (2002) , yielded the expected band of 394 bp that can also be amplified from pituitary glands together with an as yet unidentified band of $ 320 bp. K, positive control; PDH, specific band at 102 bp indicating absence of contaminating genomic DNA; 0, negative control (no cDNA).
Immunolocalization of mACh-R in normal epidermis
The m1 ACh-R could reliably be localized with Biotrend sera producing a membrane staining pattern in the upper stratum spinosum and stratum granulosum. Our own m1 serum, GP20a, and the Sigma-Aldrich rabbit m1 serum produced a more cytoplasmic staining of exactly the same cells as the Biotrend serum (Fig 3a) . The m2 antiserum produced a prominent labeling of nerves and smooth muscle cells. In addition, a weak staining of the epidermal BCL was found. A strong staining of the stratum corneum was considered unspecific (Fig 3b) . Using a monoclonal m2 antibody from Sigma-Aldrich, all fixation methods produced a nuclear stain. In addition, methanol fixed sections showed a prominent labeling of the epidermal granular layer. The m3 and m5 ACh-R antisera predominantly labeled the BCL (Fig 3c, e) , whereas the m4 antisera produced a cytoplasmic staining of all suprabasal epidermal layers (Fig 3d ) .
Figure 2
Localization of acetylcholine receptors (ACh-R) mRNA in human scalp skin by in situ hybridization. The a3 mRNA is abundant in myoepithelial cells of eccrine sweat glands (a). The a5 (b) and b4 (f) mRNA is localized predominantly in the epidermal basal layer and in a single cell layer of the stratum granulosum (arrows). The a7 signal is strongest in the granular and upper spinous layers. In the basal layer, there is only a weal signal (c). Note that on other sections, the a7 signal in the basal layer is stronger. The a9 mRNA is most abundant in the basal layer and decreases as the keratinocytes differentiate (d). b1 mRNA can readily be detected in the uppermost epidermal layers (e). Non-radioactive in situ hybridization using nickel enhanced 3,3 0 -diaminobenzidine (DAB) as chromogen. Scale bar: 50 mm.
Figure 3
Immunolocalization of muscarinic acetylcholine receptors (mACh-R) protein in human scalp epidermis. The muscarinic ACh-R isoforms show a differentiation-dependent localization in the epidermis. Although m1 is predominantly found in the upper stratum spinosum and in the stratum granulosum (GP20a, a), the m2 isoform (Biotrend) only faintly labels the epidermal basal layer. The strong signal in the stratum corneum is unspecific and cannot be reduced by preincubation with the respective peptide. The m3 isoform shows a prominent labeling of the basal layer (Biotrend, b). The m4 antisera produced a more cytoplasmic staining of suprabasal epidermal layers (Biotrend, d) and the m5 isoform is predominantly found in the basal layer, colocalizing with m3 (GP12b, e, same section as c). Scale bars: (a, b) 50 mm, (c-e) 100 mm.
Immunolocalization of nACh-R in normal epidermis There was a reproducible and strong staining of the epidermal BCL for the a3 and b4 subunit antisera (Fig 4a) .
The intensity of the a5 and b2 antisera in the BCL was highly variable, even in different parts of the same section. In addition to the localization in the BCL, we found a cytoplasmic colocalization of the a3, a5, and b2 and, to a lesser extent, also of the b4 chains in a single cell layer of the stratum granulosum, especially in parts of the epidermis with prominent keratohyaline granules (Fig 4e) . In order to identify the nature of this cell layer, we performed colocalization studies using a filaggrin antibody (Fig 4f ) . The filaggrin reactivity, however, was clearly more extended than the b2 reactivity.
Our own a7 and a9 nACh-R antisera showed a clear membrane staining, for the a7 nACh-R in the stratum granulosum and upper stratum spinosum and for the a9 nACh-R in the lower stratum spinosum and stratum basale (Fig 4b) . In some sections our a7 serum GP9a also produced a variable staining of the epidermal BCL, which was exclusively labeled by the Biotrend a7 serum (Fig 4d ) . In the granular and BCL, there was a striking colocalization of the a7 sera with the tight junction protein ZO1 (Fig 4d ) . All a10 antisera produced a variable staining of the BCL and a membrane staining of the granular layer, paralleling a7 expression (Fig 4b  0 ) . There was only a partial colocalization with our a9 nACh-R serum (Fig 4b  00 ). Using a rat monoclonal antibody against the b1 chain, we could demonstrate a membrane staining in the stratum granulosum and upper stratum spinosum. The b1 chain seemed to exactly colocalize with the a7 nACh-R (Fig 4c) whereas there was no colocalization with the a9 chain (not shown). Neither a7 nor b1 showed a colocalization with the heterooligomers in the stratum granulosum (not shown). The distribution of the different ACh-R in human scalp skin is summarized in Fig 5 .
Immunolocalization of ACh-R in cutaneous adnexal structures
Hair follicles The different compartments of human anagen hair follicles were selectively labeled by the different ACh-R antisera. In the infundibulum, we found an epidermis-like pattern for all antisera examined, with increased intensity especially for the a5, a10, b2, m3, and m5 antisera. In the subinfundibular ORS the a3, a5, b2, b4, m1, and m3 sera strongly immunolabeled the BCL whereas the central cell layer (CCL) was only weakly labeled and the companion layer (CL) remained negative (Fig 6a) . Our GP9a-and the Biotrend a7 serum decorated the BCL whereas only the GP9a serum also weakly labeled the CL. In the bulbus area, the ORS is reduced to a single cell layer, which was labeled by the Biotrend a3, b4, m3, our a7 (GP9a), and m5 (GP12b) sera (Fig 6a, c, e) . The a10 sera weakly immunolabeled the BCL of the ORS and showed a bright staining of the inner root sheath (IRS) (not shown). The b1 antibody exclusively immunostained the CL and the IRS, showing a partial colocalization with the desmosomal cadherin desmocollin 1 (Fig 6b) . The a9 and m5 antisera produced a membrane staining of the CCL whereas the BCL and the CL remained negative. The m4 serum yielded a more cytoplasmic staining of the CCL.
Apart from the b1 and a10 chain, only the a5, b2, m1, m2, m3, and m4 sera strongly immunostained the IRS (especially Huxley's layer, Fig 6d ) , whereas a3 and b4 sera only produced a weak staining. In contrast, the trichocytes that form the hair shaft were brightly labeled with a3, b4, a9, m2, m3, m4, and m5 sera (Fig 6a-f ) . In telogen follicles and in the bulge area of anagen follicles, we observed a strong immunostaining with all b2 sera (Fig 7b) . The matrix cells were only stained with the a5, a9, m3, and m4 sera.
Sebaceous glands Undifferentiated sebocytes of the basal glandular layer were brightly immunolabeled by a3, b4, a9, m3, m4, and m5 antisera (Fig 7a, b) , whereas a5, a7, and b2 sera only produced weak immunostaining and b1 and m2 remained immunonegative. The mature sebocytes of the central glandular layers reacted with a7, b2, b4, m2, and m4 antisera (Fig 7c, d ) . The sebaceous duct showed a particularly strong staining for a5, a7, and m3 sera, whereas a3, a9, and m5 sera produced only a moderate staining.
Sweat glands In myoepithelial cells of sweat gland acini, we found a prominent staining of a3, b2, b4, a9, a10, m2, m3, Immunolocalization of nicotinic acetylcholine receptors (nACh-R) protein in human scalp epidermis. The heterooligomers a3 (GP5a, a) and b4 (Biotrend, a 0 ) show complete colocalization in the epidermal basal layer (a 00 ). The homooligomer a9 (GPT1) is immunolocalized to the basal layer and the stratum spinosum (b) whereas rabbit serum a10 VIb produces a membrane staining pattern predominantly in the basal and granular layers (b 0 ) showing only partial colocalization with a9. a7 (c) and b1 (c 0 ) seem to exactly colocalize (c 00 ) in the granular layer. In contrast, the tight junction protein ZO1 (d 0 ) is localized in exactly the same cells, but shows side by side localization with a7 (GP9a). Note that both a7 and ZO1 show a dual localization in the basal, upper spinous layers and in the stratum granulosum (d 00 ). Apart from their variable localization in the epidermal basal layer, a5 (GP1a, e) and b2 (Biotrend, e 0 ) colocalize in a single cell layer in the stratum granulosum (e 00 ). The differentiation-related antigen filaggrin is also expressed in the granular layer (f) whereas b2 is restricted to single cells in the upper granular layer and also shows a weak expression in the basal layer (f 0 ). Colocalization of filaggrin and b2 in single cells (f 00 ). Scale bar: 50 mm.
Figure 5
Schematic presentation of acetylcholine receptors (ACh-R) distribution in human scalp epidermis. On the basis of our in situ hybridization and immunofluorescence data, the distribution of ACh-R in human scalp epidermis can be summarized as follows: in the basal layer, there is a variable expression of the a3, a5, b2, and m2. The strongest expression in most specimens was found in the basal layer for the a3, b4, a9, a10, m3, and m5 chains whereas a5, b2, a7, and m2 chains showed a highly variable and often very weak expression intensity. In the lower spinous layer only the a9 and m4 chains could be detected in all specimens whereas m3 and m5 expression was variable.
In the upper spinous layer and in the stratum granulosum, the a7, a10, b1, m1, and m4 chains predominate. In some specimens, also the m3 and m5 expression reaches up to this height. In the cytoplasm of a single cell layer of the upper stratum granulosum, the a5 and b2 predominate, but in some specimens, also a3 and b4 colocalize in these cells.
m4, and m5 sera whereas a5, a7, and m1 sera produced a less intense staining. The identity of myoepithelial cells was confirmed by their characteristic shape and by colocalization with a-smooth muscle actin (Fig 8a, d ) . The acinar cells were only weakly labeled by a9, a10, b2, m1, m3, and m4 sera. The sweat duct epithelium was brightly immunolabeled by a3, b2, b4, a7, a10, m4, and m5 sera, whereas the a5, a9, m1, and m3 sera only produced a weak staining. In some sections m3 immunostaining was pronounced in the BCL of the sweat duct epithelium. The b1 chain was not detected in sweat glands or sweat ducts (Fig 8) .
Discussion
Starting from the pioneering work of Grando and coworkers, we attempted to molecularly and phenotypically characterize the complete extraneuronal cholinergic system of the skin as a prerequisite for further functional studies. Using PCR, we confirmed the previously reported presence of a3, a5, a7, a9, a10, b2, and b4 nACh-R and of m1, m3-m5 mACh-R mRNA in human skin (Grando et al, 1995; Ndoye et al, 1998; Nguyen et al, 2000) . In addition, we could unequivocally demonstrate the presence of b1 nACh-R mRNA and protein in human epidermis. In contrast we were not able to demonstrate the presence of a2, a4, a6, b3 nACh-R mRNA in human skin. The presence of m2 mACh-R in PCR experiments is explained by the obvious m2 expression in cutaneous adnexal structures. In good agreement with previous studies and in contrast to oral squamous epithelium, epidermis from scalp skin only shows a faint m2 staining of the BCL together with an unspecific signal in the stratum corneum (Ndoye et al, 1998; Arredondo et al, 2003) . By immunohistochemistry and ISH, there seems to be a highly variable expression of the nACh-R in the epidermis, especially of the heterooligomeric species of the a3 Ã type. To date, we were not able to systematically elucidate the factors that cause this variability in expression of the heterooligomeric nACh-R subunits observed in different studies and between different specimens within a single study. Putative factors include age, atopic disposition, smoking habits or minimal trauma. In choosing only one body site, i.e. the scalp, and excluding smokers from our study, we were able to reduce the previously observed variability significantly. Differences in body site might also explain contrasting results obtained with the same antibodies (e.g. anti-a3, -b2) by other authors (Grando et al, 1995) .
Of the nACh-R subunits, the a3, a5, b2, and b4 chains all colocalize in the BCL of the epidermis and are hence able to form a functional ACh-R. To variable amounts, they also colocalize in a single cell layer of the stratum granulosum, producing a more cytoplasmic staining. In this layer, we found a strong reaction for the a5 and b2 chains that are known to alter the pharmacological properties of the ACh-R (Gerzanich et al, 1998; Curtis et al, 2000) , whereas the a3 and b4 chains were less frequently detected. The cytoplasmic colocalization of different heterooligomers in a single cell layer of the stratum granulosum has not been observed before. The special layer in which they occur is localized in the upper stratum granulosum as judged by filaggrin (Fig 4f ) and CK2e expression. It is a remarkable observation that the a3, a5, b2, and b4 subunits as well as the a7, a10, and b1 subunits show a distinct, but overlapping pattern of expression in the granular layer.
The homooligomeric nACh-R subunits a7 and a9 show a clearly distinct distribution within the epidermis. Although the a9 ACh-R are prominent in the BCL and lowest suprabasal layers, the a7 ACh-R can be found in the upper stratum spinosum and in the stratum granulosum, clocalizing with the a10 and b1 chain. Normally, the b1 chain, together with the a1, g, d, e chains, forms the ACh-R present at the neuromuscular junction. There has been only been one previous report in which b1 mRNA was detected in an epithelial cell line (Summers et al, 2003) . It is completely unclear, whether the b1 chain, alone or together with other subunits, can form a functional ACh-R in the epidermis. An attractive possibility would be the association of the b1 subunit with the a7 chain, an assumption favored by the exact colocalization of the two isoforms in the upper epidermis. In other epithelial compartments of the skin, however, these isoforms do not colocalize, e.g. in hair follicles (compare Table III ). Hence, the b1 isoform might also form homooligomeric nACh-R in human epidermis. The a10 subunit is the most recent member of the epidermal ACh-R subunits. Together with the a9 chain it forms functional Ach-R in various organs (Sgard et al, 2002; Lips et al, 2002) . Much to our surprise, we found that in the epidermis a10 expression parallels a7 and b1 expression rather than a9 nACh-R subunit expression. In the other compartments of the skin, there was a complete dissociation of the expression patterns for these four subunits (i.e. a7, a9, a10, and b1) indicating that either a10 might be able to form functional receptors with different subunits, or that a10 like b1 might be able to form functional receptors on its own, which however has never been demonstrated in vitro (Elgoyhen et al, 2001) . Interestingly, a9 and a10 expression is also differentially regulated in fetal development, at least in the rat cochlea (Morley and Simmons, 2002) . Therefore, the functional relevance of the a10 and b1 nACh-R in human epidermis remains to be determined.
The granular layer shows the highest concentration of ACh throughout the epidermis. In conjunction with the fact that the highest calcium concentrations within the epidermis have also been demonstrated in the granular layer Distribution of acetylcholine receptors (ACh-R) in human anagen hair follicles. The heterooligomers b2 (GP14a, a 0 ) and b4 (Biotrend, a 00 ) colocalize in the outer root sheath (ORS) of anagen hair follicles with predominance in the basal layer. In the inner root sheath (IRS), the b2 serum shows a stronger reaction in the Huxley's layer (arrow in a), whereas there is only a weak b4 staining (a 00 ). The signal in matrix cells and trichocytes is hardly above background. The rat mab against b1 specifically stains the entire IRS (b, b 00 ), whereas in the ORS, there is only a weak staining of the companion layer. The staining pattern resembles the desmosomal protein desmocollin 1 (mab Dsc1-U100), which also specifically stains the IRS, although with stronger intensity in the lower parts of the follicle (b 0 ). There was a strong reaction of the b1 mab in the basement membrane zone of the dermal papilla (b 00 ). In large parts of the epidermis and the ORS, m3 (c 0 , Biotrend) seems to colocalize (arrow in c) with the desmosomal protein desmoglein 2 (c 00 , mab Dsg2-G96). In the bulb area, however, a dissociation becomes evident: whereas desmoglein 2 is not expressed in matrix, IRS and trichocytes (c 00 ), m3 shows a prominent staining of IRS and trichocytes (c 0 ). M4 is broadly expressed in the anagen follicle, as evidenced by the Biotrend serum (d 00 ). In the IRS, m4 colocalizes with the desmosomal protein desmoglein 1 (d, d 0 ). M2 shows only a weak staining of the ORS, whereas the IRS is prominently labeled (Biotrend, e 0 ). M3 (f 0 , Biotrend) colocalizes with m5 (GP12b) in the ORS and trichocytes (yellow color in f ) whereas in the matrix and IRS, m5 is only weakly expressed (e 00 , f 00 ). Scale bars: (a, c, e, f ) 150 mm, (b) 100 mm, (d ) 50 mm. (Denda et al, 2003) , expression of homooligomeric nACh-R such as a7 that preferentially gate calcium suggests that they are involved in modulating terminal keratinocyte differentiation and barrier function (Fuchs, 1990; Takeichi, 1990; Seguela et al, 1993) . Apoptotic secretion is another process within the granular layer that may be influenced by ACh possibly mediated by a3 Ã complexes in this special localization (Nguyen et al, 2001) .
To date, there has been no data available on ACh-R expression in hair follicles or sebaceous glands. One previous Expression of acetylcholine receptors (ACh-R) in sebaceous glands. Like in the epidermis, the a3 (GP5b, a 0 ) and b4 (Biotrend, a 00 ) isoforms colocalize in the basal layer of the sebaceous gland (a). Note that only b4 (a 00 ) is expressed in the mature sebocytes (arrow in a) where it colocalizes with a5 (not shown). The b2 serum (GP14a, b 0 ) immunolabels the epidermal and sebaceous basal layers. Note a strong upregulation in club cells of a telogen follicle whereas b4 reactivity does not change compared with the epidermal basal layer. Although in the epidermis, a7 and b1 show an almost identical staining pattern, only a7 (GP9a, c 00 ) is expressed in mature sebocytes, b1 remains negative (c 0 ). In sebaceous glands a9 (GPT1, d 0 ) and a10 (a10 VIb, d 00 ) show only partial colocalization in the basal layer, where both subunits produce a bright immunostaining. Only the a10 subunit is found in mature sebocytes (d). The ''inhibitory'' muscarinic ACh-R (mACh-R) m2 (Biotrend, f 0 ) and m4 (Biotrend, e 00 ) are both up-regulated in mature sebocytes as compared with undifferentiated sebocytes of the basal seboglanular layers, whereas the ''stimulatory'' mACh-R m3 (not shown) and m5 (GP12b, e 0 , f 00 ) are both expressed in basal sebocytes. Note single cells that show strong expression of m4 and m5 (arrows in e). Scale bar: 100 mm. study focused on the high-affinity choline transporter 1, which can be found in the epidermis and in cells of the IRS (Haberberger et al, 2002) . We found a highly complex expression pattern of the different ACh-R subunit genes in the epithelial compartments of human hair follicles and sebaceous glands, showing some analogy to established systems of differentiation markers, like the desmosomal cadherins (Kurzen et al, 1998) . Although the a7, a10, and the b1 subunits show precise colocalization in the upper epidermis, their expression patterns in the hair follicle ) . The a9 chain (GPT1, c 0 ) incompletely colocalizes with a10 (a10 VIb) in the sweat glands, often displaying a side by side pattern (arrow in c). Vessels (Ves) are exclusively labeled by a10 sera. The muscarinic m1 receptor is only weakly expressed in the myoepithelial and acinar cells, the ductal cells show a stronger reaction (d 00 ). Identification of myoepithelial cells via a-smooth muscle actin (d 0 ). Comparison of m2 (Biotrend, e 0 ), m3 (Biotrend, f 00 ), and m5 (GP12b, e 00 , f 0 ) reveals a predominance of these isoforms in the myoepithelial cells as indicated by yellow coloring in (e) and (f). In addition m3 is expressed in the acinar cells (arrow in f on green pseudocolor). Vessels are prominently m2 immunopositive (arrow in e). Note strong m5 expression in the outer root sheath of an adjacent hair follicle in (e). Scale bar: 50 mm.
diverge: the a7 and a10 subunits are confined to the BL and CL of the ORS, whereas b1 is confined to the CL. In the IRS a10 and b1 both show a strong expression whereas a7 remains negative. Of all the nACh-R, only the a9 shows a strong expression in the CCL of the ORS. The only other Ach-R found in this layer are the m4 and m5 mACh-R. The b1 shows a strong expression in the CL and in the IRS, a pattern reminiscent of the desmosomal cadherin desmocollin 1. In colocalization studies, however, we could demonstrate that both proteins do not fully colocalize. Desmocollin 1 is slightly further extended both in the epidermis and in the hair follicle (Fig 6b) . Like in the epidermis, the a9 and m3 chains showed pattern reminiscent of desmoglein 2 and 3 (Kurzen et al, 1998) with broad expression in the ORS and the trichocytes of the hair shaft. But again, on close inspection, a dissociation of the different pattern becomes evident with m3 being expressed also in the IRS. In addition, high magnification of laser scan overlay images revealed side by side and not ''true'' co-staining.
The heterooligomeric subunits were mostly confined to the BCL of the ORS, with b2 being particularly strongly expressed in the bulge area, where the hair stem cells are suspected to reside (Lyle et al, 1999) . Taking into account the complex biology of the hair follicle, clearly further studies are needed to clarify the influence of ACh and ACh-R on hair cycle and hair growth (Stenn and Paus, 2001) .
Smoking is known to negatively influence several skin diseases, especially acne vulgaris (Schafer et al, 2001) . Since sebum production is closely linked to the development of acne lesions, effects of chronic nicotine exposure on the course of acne lesions might be mediated by nACh-R present in sebaceous glands, resulting in increased sebum production or altered sebum composition. It has to be kept in mind, however, that cigarette smoke contains a plethora of different toxins, making it difficult to attribute an observed clinical effect to one component (Mills et al, 1993) and hence effects of smoking might not completely correspond to effects of nicotine. In this respect, further studies are needed. We could demonstrate an upregulation of the ''inhibitory'' mACh-R m2 and m4 in mature sebocytes as compared with undifferentiated sebocytes of the basal seboglanular layers, whereas the ''stimulatory'' mACh-R m3 and m5 are both expressed in basal sebocytes. Together with the presence of the nACh-R this finding strongly advocates for ACh as a secretagogue for sebum production and a promotor of sebocyte differentiation.
The anatomy of eccrine sweat glands has been known for some decades, whereas sweat gland innervation has been a difficult research area, depending mainly on pharmacologic observations. It is well established that sweat glands respond to innervation by the sympathicus, a process mediated presynaptically by adrenergic receptors (Rechardt et al, 1976) . The postganglionic sympathetic neurons terminating in close proximity to the myoepithelial cells of eccrine sweat glands, release ACh and at the same time produce acetylcholinesterase (Ostlere et al, 1995) . It could be shown that sweat production can be blocked effectively using both antiadrenergic and anticholinergic compounds. Sweating, on the other hand, can be induced by injection of ACh, nicotine, carbachol (which activates all ACh-R and blocks AChE) and other cholinomimetic compounds. This effect can be antagonized by atropine and not by hexamethonium bromide, an unspecific nACh-R antagonist. This observation together with results obtained in different animals led to the assumption that mostly m3 and m4 mACh-R were mainly involved in sweat generation (Longmore et al, 1985; Sato and Sato, 1987; Grant and Landis, 1991; Smith et al, 1992) . Our results unequivocally demonstrate the presence of both nACh-R and mACh-R in myoepithelial and acinar cells of eccrine sweat glands. This finding indicates that sweat production in the acinar cells and sweat expulsion through contraction of myoepithelial cells are mediated by different nACh-R and mACh-R.
Altogether, we could demonstrate a highly regulated distribution of nACh-R subunits and mACh-R isoforms in human scalp epidermis and adnexal structures supporting previously observed effects of cholinergic compounds on keratinocyte biology (Grando et al, 1995; Nguyen et al, 2001) . Our data provide the basis for further research on the role of the cholinergic system in hair biology, sebaceous gland biology, and sweat gland biology.
Materials and Methods
Tissues Normal human non-smoker's skin (scalp, back, leg) was obtained after informed consent from the margins of routine surgical procedures. Samples were frozen in isopentane cooled in liquid nitrogen immediately after removal and stored at À801C or fixed in 4% buffered formaldehyde and embedded in paraffin.
PCR RNA was extracted from split skin (depth 2 mm) using the RNeasy fibrous tissue Kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). cDNA was synthesized from freshly isolated mRNA after DNAse treatment using Superscript II (Life Technologies, Eggenstein, Germany). In addition, a human footsole (epidermis and dermis) cDNA library was used (Kurzen et al, 1998) . For PCR analyses 100 ng of the respective cDNA and 20 pmol primers were used per 25 mL reaction tube. Hot start PCR was performed using AmpliTaq Gold (Applied Biosystems, Weiterstadt, Germany) according to standard protocols on a Peltier thermal cycler (MJ Reearch Inc., Waltham, Massachusetts). The annealing temperature was optimized for all primer pairs and ranged from 551C to 641C (Table I) . PCR products were visualized on standard 2.5% agarose gels with ethidium bromide. Amplified products of expected sizes were excised from the gels, purified (QIAquick PCR Purification Kit, Qiagen), cloned using the TOPO TA Cloning Kit (Invitrogen, Karlsruhe, Germany) and sequenced (A. Hunzicker, German Cancer Research Center Heidelberg). To exclude contaminating genomic DNA, PDH (Acc.#: XM_113395) primers that produce fragments of 102 bp in the presence of cDNA and fragments of 200 bp in presence of genomic DNA were used. All PCR experiments were performed at least twice.
ISH Cloned nACh-R cDNA from PCR experiments was used to produce digoxigenin (DIG)-labeled antisense and sense (negative control) cRNA according to the manufacturer's instructions (DIG RNA Labeling kit, Roche, Mannheim, Germany). A positive control was provided by the manufacturer. Labeling intensity was controlled using a dot blot procedure. Labeled cRNA was detected using a horseradish-coupled anti-DIG antibody (Dianova, Hamburg, Germany) and the ECL System (Amersham, Freiburg, Germany).
ISH was performed at least twice on 9 mm cryostat sections, fixed RNAse free in 4% buffered paraformaldehyde containing 5% sucrose. After thorough washing, proteinase K digestion (20 min) and prehybridization (60 min, 371C), ISH was performed over night at 421C-541C using 10-30 mg DIG-labeled cRNA per slide. After intense washing, non-hybridized cRNA was removed by RNAse digestion. Hybridized cRNA was detected using a biotin-coupled anti-DIG antibody (Dianova), peroxidase-coupled streptavidin (Dianova) and nickel enhanced 3,3 0 -diaminobenzidine Sigma-Aldrich (Munich, Germany) as chromogen. Sections were embedded after dehydration using Entellan (Merck, Darmstadt, Germany) and analyzed under a Leitz Diaplan photomicroscope (Leitz, Wetzlar, Germany).
Immunofluorescence staining of human skin For immunofluorescence analysis, 5 mm cryostat sections of human skin from various body sites were either used air dried and unfixed or fixed either in ice-cold acetone or in freshly prepared 3% buffered formaldehyde containing 7% sucrose. Immunofluorescence reactions were performed at least 10 times on different specimens according to standard procedures (Kurzen et al, 2002) . After blocking with 5% non-fat dry milk and 1% BSA in Tris-buffered saline (TBS), the primary antibodies were applied to the specimens for 1 h at room temperature or for 12 h at 41C. The following secondary antibodies were applied for 1 h at room temperature: Cy-2-and Cy-3-coupled preabsorbed goat anti-mouse, anti-rabbit, and anti-guinea-pig antisera and a Cy-3-coupled rabbit anti-goat antiserum, all obtained from Dianova.
In order to enhance the signal intensity, biotin-coupled secondary antibodies were used. Antibody binding was visualized with Cy-2-or Cy-3-coupled streptavidin (Dianova). Negative controls were performed by replacing the primary antibody with phosphatebuffered saline (PBS) or an irrelevant, species-matched antibody. Washes (3Â10 min) were performed after each step in PBS or TBST. Preincubation of all guinea-pig sera with a 5-fold molar excess of the respective peptide used as immunogen was performed E1 and C3 denote domains of the respective protein from which the peptide used for immunization was chosen. All sera displayed showed a strong reactivity with the antigen, immunofluorescence reactivity could be completely eliminated by preincubation with the immunogen.
ACh-R, acetylcholine receptors.
routinely for 6 h at 371C in PBS. The staining was observed and visualized with a Laser Scan Confocal Microscope (LSCM; Type LSM 510 UV, Zeiss, Jena, Germany).
Production of antisera against ACh-R The following peptides were used to immunize guinea-pigs according to standard protocols. Peptides from the first and third extracellular domain (E1, E3) and the second (nACh-R) and third (mACh-R) cytoplasmic domain (C2, C3), which have only limited similarity to other isoforms, were selected. Peptides were chosen in order to minimize possible cross-reactivities and to maximize antigenicity and solubility. Two animals were immunized with each peptide. Only in the case of the a9 chain, both peptides were mixed and injected into two animals. The sera obtained were screened by a dot blot procedure for reactivity with the immunogens. High titer sera were affinity purified against the immunogen peptides using the AminoLink Immobilization Kit (Pierce, Bonn, Germany). The guinea-pig sera displayed in Table II shows a strong reaction with the immunogen and produces a membrane staining in immunofluorescence, which was enhanced after affinity purification and absent after preincubation with the respective peptide (Table II) .
Additional antibodies used In addition to our own guinea-pig antisera, we analyzed commercially available affinity-purified antisera from Santa Cruz Biotechnologies (Heidelberg, Germany): rabbit anti-a3 (sc-5590), a7 (sc-5544), m1 (sc-9106), m4 (sc-9109), and m5 (sc-9110), goat anti-a3 (sc-1771), a5 (sc-9345), a7 (sc-1447), m1 (sc-7470), m3 (sc-7474), m4 (sc-7476), and m5 (sc-7478); Biotrend (Cologne, Germany): rabbit anti-a3 (AS-5611S), a5 (AS-5621S), a7 (AS-5631S), b2 (AS-5646S), b4 (AS-5656S), m1
(AS-3701S), m3 (AS-3741S), m4 (AS-3761S), and m5 (AS-3781S). The Biotrend sera correspond to those published by Grando et al (1995) and Ndoye et al (1998) . M2 rabbit antiserum corresponding to AS-3721S from Biotrend was a kind gift of S. A. Grando (San Francisco) . Rat monoclonal anti-b1 (clone 111) and polyclonal rabbit anti-M2 (No.: 9559) were from Sigma-Aldrich. The a10 antisera a10 I (rabbit), a10 VIb (rabbit), a10V (guinea-pig), were kind gifts of W. Kummer (Gieen, Germany). Characterization of the a10 antisera has been published in Lips et al (2002) , mab HHF35 against a-smooth muscle actin (Enzo Diagnostics, Farmingdale, New York), mab 15C10 against filaggrin (Novocastra, Newcastle, UK), mab Dsc1-U100 against desmocollin 1, mab Dsg1-P124 against desmoglein 1, mab Dsg2-G96 against desmoglein 2 (all from Progen, Heidelberg, Germany).
